体重指数影响胸主动脉腔内修复术的指征但不影响结局
本研究回顾分析2007年10月至2020年1月在一家大型三级医院接受胸主动脉腔内修复术(TEVAR)的204例患者,按体重指数(BMI)分为正常、超重和肥胖三组。结果显示三组在围手术期并发症、再干预及30天和1年生存方面无显著差异,但肥胖组因B型主动脉夹层行TEVAR的比例最高。
要点
- 肥胖组B型主动脉夹层占36.4%,正常BMI组孤立性胸主动脉瘤占63.9%。
- 三组术中并发症、院内及出院后并发症、30天重返手术室无显著差异。
- 再干预、30天死亡及1年总生存三组相似,多因素分析无显著差异。
核心结论
- 正常体重、超重和肥胖患者接受TEVAR后并发症、再干预和死亡率无显著差异,血管外科医生可对不同BMI范围患者实施TEVAR而不影响结局。
研究设计与样本
- 回顾性分析2007年10月至2020年1月在一家大型三级医院接受TEVAR的患者。
- 共纳入204例符合标准患者,按BMI分为正常组(18.5-25 kg/m2,65例)、超重组(25-30 kg/m2,78例)和肥胖组(>30 kg/m2,61例)。
- 主要结局为30天和1年生存率,次要结局包括术中、院内及出院后并发症(Clavian-Dindo分类)和再干预。
主要发现
- 肥胖组患者较超重组和正常组年轻(平均年龄62.2岁 vs 66.7岁 vs 70.7岁,P=0.003)。
- 肥胖组B型主动脉夹层比例最高(36.4%),正常BMI组孤立性胸主动脉瘤比例较高(63.9%)。
- 术中并发症、院内并发症、出院后并发症及30天重返手术室在各组间无显著差异。
- 再干预几率在单因素和多因素分析中均无显著差异,无再干预生存率Kaplan-Meier分析log-rank检验P=0.22。
- 30天死亡率和1年总生存率在各组间相似,单因素和多因素对数回归显示肥胖组与正常组30天死亡可能性无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There are limited studies looking at thoracic endovascular aortic repair (TEVAR) outcomes in obese and overweight patients. Our objective was to determine the rate of complications, reintervention, and short-term mortality in normal weight, overweight, and obese patients undergoing TEVAR. METHODS: Patients undergoing TEVAR at a large tertiary hospital from October 2007 to January 2020 were analyzed. Patients were stratified into 3 cohorts based on body mass index (BMI): normal (18.5-25 kg/m2), overweight (25-30 kg/m2), and obese (>30 kg/m2). Primary outcomes were 30-day and 1-year survival. Intraoperative, in-hospital, and postdischarge complications were assessed as secondary outcomes using the Clavian-Dindo classification system. In addition, reinterventions associated with the index TEVAR procedure as a secondary outcome. RESULTS: Among 204 patients fitting the study criteria, we identified 65 with normal BMI, 78 overweight, and 61 obese patients. Obese patients were younger than the overweight and normal BMI patients (mean age 62.2 vs. 66.7 vs. 70.7, respectively, P = 0.003). In terms of TEVAR indication, the obese cohort had the highest percentage of patients with type B aortic dissection (36.4%), while the normal BMI cohort had the higher proportion of patients undergoing TEVAR for isolated thoracic aortic aneurysm (63.9%). Intraoperative complications did not significantly differ between cohorts. Postoperatively, in-hospital complications, postdischarge complications and 30-day return to the operative room did not differ significantly between study cohorts. Odds of reintervention did not differ significantly between cohorts, both on univariate and multivariate analysis. Log-rank test of Kaplan Meier analysis revealed no difference in reintervention-free survival (P = 0.22). Thirty-day mortality and 1-year overall survival were similar across cohorts. Both univariate and multivariate logarithmic regression revealed no difference in likelihood of 30-day mortality between the obese and normal cohort. CONCLUSIONS: There were no measurable differences in complications, reinterventions, or mortality, suggesting that vascular surgeons can perform TEVAR across a spectrum of BMI without compromising outcomes.
引用
- Cooke PV, Chennareddy S, Kalagara R, et al. Body Mass Index Impacts Indication But Not Outcomes of Thoracic Endovascular Aortic Repair. Ann Vasc Surg. 2023. PMID: 37922959. doi:10.1016/j.avsg.2023.09.089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。